{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Cancer Immunotherapy Paves the Way for Better Understanding of COVID-19

Activity Steps

Purpose of Activity

To provide an overview of how knowledge learned in cancer immunotherapy may help practitioners individualize treatments based on the different immune responses of their patients with COVID-19.

Learning Objectives/Outcomes

After completing this continuing education activity you will be able to:

  1. Evaluate how cancer research has contributed to our current understanding of COVID-19.
  2. Assess how the COVID-19 pandemic has affected the current state of scientific research.
  3. Summarize what we have learned about the role of immunology in our treatment of patients with COVID-19.
Price: $12.95


  • ANCC 1.0 CH
  • DC - BON 1.0 CH
  • FL - BON 1.0 CH
  • GA - BON 1.0 CH

Lippincott Professional Development is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation. This activity is also provider approved by the California Board of Registered Nursing, Provider Number CEP 11749. Lippincott Professional Development is also an approved provider of continuing nursing education by the District of Columbia Board of Nursing, Florida Board of Nursing, and Georgia Board of Nursing, #50-1223.

Test Code: OT0820
Published: August 2020
Expires: 7/3/2022
Sources: Oncology Times
Required Passing Score: 7/10 (70%)
Authors: Peggy Eastman